key: cord-0732995-t5i2eju2
authors: Ganguly, Mimi; Nandi, Alolika; Banerjee, Paramita; Gupta, Purbasha; Sarkar, Subhajit Dey; Basu, Surupa; Pal, Priyankar
title: A comparative study of IL‐6, CRP and NT‐proBNP levels in post‐COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients
date: 2021-11-08
journal: Int J Rheum Dis
DOI: 10.1111/1756-185x.14236
sha: c42b6c8183c9ae2b8e75c143068e16cc8ab2b2c4
doc_id: 732995
cord_uid: t5i2eju2

BACKGROUND: Post‐COVID multisystem hyperinflammatory syndrome in children (MISC) has clinical and laboratory similarities with Kawasaki disease (KD). Inflammatory markers like C‐reactive protein (CRP), interleukin 6 (IL6) as well as N‐terminal probrain natriuretic peptide (NT‐proBNP) are elevated in both. This study attempts a comparative analysis of the 3 markers in an attempt at early differentiation for planning appropriate management. METHODOLOGY: This analytical study conducted at the Institute of Child Health, Kolkata, India compared the levels of the above 3 markers at admission between 72 patients with KD, 30% of whom had coronary artery lesions (CALs) collected over a period of 18 months (Jan 2017‐June 2018), with 71 MISC patients over a period of 6 months (July 2020‐December 2020). The non‐parametric Mann‐Whitney U test was used to test for similarity in distributions of the samples of CRP, NT‐proBNP and IL6 in KD and MISC patients using correction factor for similar ranks. The 3 parameters were compared using receiver operating characteristic (ROC) curve analysis. RESULTS: Mean IL6 value in KD was 83.22 pg/mL and in MISC 199.91 pg/mL, which was not found to be statistically significant (P = .322 > .05).However mean NT‐proBNP (914.91 pg/mL) with CRP level (96.32 mg/L) in KD was significantly lower (P < .05 for both cases) than that in MISC (9141.16 pg/mL and 145.66 mg/L respectively). ROC analysis showed NT‐proBNP has the best sensitivity and specificity in predicting MISC. CONCLUSION: NT‐proBNP and CRP are significantly higher among MISC patients; ROC analysis shows levels >935.7 pg/mL and >99.55 mg/L respectively might act as a guide to differentiate between them.

The COVID-19 pandemic originated in Wuhan in December 2019 and rapidly spread worldwide. Few months following onset of the pandemic there were global reports of a new hyperinflammatory syndrome predominantly affecting healthy children and adolescents, the majority of them requiring hospitalization and intensive care support. Named variably as pediatric hyperinflammatory multisystem syndrome (PIMS) or multisystem hyperinflammatory syndrome in children (MISC), the disease was noted to have certain clinical as well as laboratory similarities with Kawasaki disease (KD). 1,2 KD is an idiopathic multisystem inflammatory disease characterized by vasculitis of small and medium sized arteries, notably involving coronary arteries.

Both MISC and KD are childhood diseases presenting with fever with overlapping features like nonpurulent bilateral bulbar conjunctivitis, rashes, mucositis, lymphadenopathy and edema that sometimes make them clinically indistinguishable. Inflammatory markers like C-reactive protein (CRP), interleukin 6 (IL-6) are elevated in both the conditions along with serum nitrogen terminal probrain natriuretic peptide (NT-proBNP), 3 a marker for myocardial strain.

Although the 2 diseases have clinical as well as similar laboratory features, the prognosis and treatment modality vary and hence the need for early differentiation. This study attempts a comparative analysis of the above 3 common lab markers pertaining to both the diseases in an attempt to distinguish them early for planning appropriate management.

The study was conducted at the Institute of Child Health, Kolkata, India. This is an analytical study comparing IL-6, CRP 4 and NT-proBNP (unpublished data) levels between 72 patients with KD of which 30% had coronary artery lesions (CALs), collected over a period of 18 months in the pre-COVID era 4 (Jan 2017-June 2018), with 71 MISC patients over a period of 6 months (July 2020-December 2020) admitted at the same institute. The MISC patients were diagnosed on the basis of the World Health Organization criteria 5 and American Heart Association criteria 6 was used for KD diagnosis.

Institutional ethics committee approval was taken (IEC/241/2021) prior to conducting the study.

All the KD and MISC patients in the study were diagnosed on the 4th-6th days of fever. Venous blood samples for IL-6, CRP and NT-proBNP together with other necessary investigations were drawn at admission prior to institution of any therapy and evaluated at the biochemistry department. The serum concentrations of CRP were quantitatively determined by particle-enhanced turbidimetry on a Roche Integra 400 Plus © biochemistry analyzer. Linearity was until 200 mg/L. Biological reference interval was <5 mg/L and serum IL-6 was measured on the Roche Cobase411 © immunoassay analyzer with a linearity until 5000 pg/mL and biological reference interval was <7 pg/mL. Estimation of NT-proBNP was done by Roche e411 Immunoassay Autoanalyzer using electrochemiluminescence immunoassay method.

Data was collected and entered in an Excel spreadsheet.

For statistical analysis, Scipy library in Python 3 and its library functions were used. Sample values for KD and MISC were independently obtained. The non-parametric Mann-Whitney U test was used to test for similarity in distributions of the samples of CRP, NT-proBNP and IL-6 levels in KD and MISC patients using correction factor for similar ranks. The difference in distributions of values was considered significant if P value for the test was less than .05. All analyses were done in Jupyter Notebook environment. Receiver operating characteristic (ROC) curve analysis of the 3 indices at admission for both the diseases were also performed and optimum cut off values for the respective parameters was calculated by using Youden's J Index.

Seventy-one patients with MISC were admitted during the study period from July 2020-December 2020. The mean duration of fever at presentation (mean ± SD) was 5 ± 0.57 days for PIMS and 8.92 ± 2.82 days for the KD patients. Median age for KD was 19 months with interquartile range (IQR) of 13.75-30.5 months and for the MISC was 11 years with IQR of 3 years.

Since the admitting institute is a non-COVID hospital, none of the MISC patients in the study were reverse-transcription polymerase chain reaction positive. There were 42.25% of MISC patients who had history of exposure to the virus, 91% were found to be positive for SARS-COV2 immunoglobulin G. Intensive care admission was needed by 45% (n = 32) of the patients and 29.5% (n = 21) required inotropic support. Cardiac symptoms were present in 57.74% (n = 41), mostly as myocarditis (disproportionate tachycardia, electrocardiogram and echocardiographic changes) of which 29.5% had low ejection fraction varying from 35% to 47%, and 27% had CALs.

The majority (91.5%, n = 65) of the 71 MISC patients received intravenous immunoglobulin (IVIg), mostly at a dose of 2 g/kg. However, 7 adolescents because of the need for a large dose and consequent financial burden, were administered 1 g/kg in conjunction with corticosteroids. Methylprednisolone only was given to 4 patients and 40 children (56.3%) received steroids + IVIg. Three patients who presented only with fever and no organ involvement had a spontaneous remission without any treatment. All patients additionally received antiplatelet doses of aspirin. All of them responded to therapy, although patients with cardiac involvement and higher inflammatory markers at presentation required higher dosages of steroids (methylprednisolone 10-30 mg/kg/d for 3-5 days).

CRP levels were available for all MISC patients; however, data on NT-proBNP and IL-6 were available for 53 and 34 patients, respectively. These data were compared to similar data collected from 72 previously diagnosed KD patients (30% of them having CALs), complete data sets being available for each one of them.

Mean IL-6 in KD of those with CALs was 143.60 pg/mL, which was about 3 times higher than in those without CALs (mean = 52.90 pg/ mL); mean for the entire group being 83.22. Mean IL-6 among the MISC patients was 199.91 pg/mL. On testing for similarity in distributions of IL-6 levels in KD and MISC patients, the difference between the 2 groups was found to be statistically not significant (P = .322).

Testing the other 2 parameters, the mean NT-proBNP (pg/mL) levels in KD (mean = 914.91) was significantly lower (P = .00002) than NT-proBNP levels in MISC patients (mean = 9141.16). Again, the mean CRP levels (mg/L) in KD (mean = 96.32) was significantly lower (P = .043) than CRP in MISC patients (mean=145.66; Table 1 ).

We also compared the 3 laboratory parameters, that is CRP, IL-6 and NT-proBNP prior to administration of any treatment in both KD and MISC patients by performing ROC curve analysis ( Figure 1 We also tried to correlate and analyze the NT-proBNP values in MISC patients with cardiac involvement and those without (Figure 2 ).

Of the 71 MISC patients, 39 presented with cardiac involvement, 21 had coronary artery aneurysms (z score >2.5), 24 with myocardial dysfunction (ejection fraction < 55%) and 6 had both. Correlation study was done to calculate Pearson's correlation coefficient using Although previously alluded to, 14, 15 statistical analysis in this study conclusively shows that NT-proBNP and CRP levels are significantly higher among MISC patients in comparison to KD with elevation of these parameters; >935.7 pg/mL and >99.55 mg/L at admission respectively might act as guides as to the need for more aggressive management.

Applying the same cutoffs to the present cohort, in which 53/71

MISC patients have data available for both NT-proBNP and CRP, 52.8% had both parameters above the cut off values at diagnosis.

Further, 75% of these patients had severe cardiac involvement and required a combination of IVIg + steroids for battling the cytokine storm.

CRP and NT-proBNP levels are significantly higher in MISC patients as compared to KD and can be used as laboratory markers in distinguishing these clinically overlapping entities.

The authors would like to thank Debraj Pal for the statistical analysis in the study.

Priyankar Pal https://orcid.org/0000-0003-3273-6218

Multisystem inflammatory syndrome in children: is there a linkage to Kawasaki disease?

Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-Cov-2

Biomarker profile in pediatric inflammatory multisystem syndrome temporarily associated with SARS-Cov-2 (PIMS-TS)/multisystem inflammatory syndrome in children (MIS-C)

A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in kawasaki disease patients: a prospective study

Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific Brief

Diagnosis, treatment and long-term management of Kawasaki Disease: a scientific statement for health professionals from the american heart association

Multi-system inflammatory syndrome in a child mimicking Kawasaki disease

Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management

Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children

C-reactive protein levels in the early stage of COVID-19

A decade of NT-proBNP in acute Kawasaki Disease, from physiological response to clinical relevance

Usefulness of natriuretic peptide for the diagnosis of Kawasaki Disease: a systematic review and meta-analysis

Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: a meta-analysis

Paediatric multisystem inflammatory syndrome temporally associated with SARS-Cov-2 mimicking Kawasaki Disease (Kawa-COVID-19): a multicentre cohort

Multisystem inflammatory syndrome in children in New York state

A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients